Journal for ImmunoTherapy of Cancer (Nov 2023)
1047 Protein design and inducible expression allow context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies
- Summer Zhuang,
- David Chian,
- Hajime Hiraragi,
- Thaddeus M Davenport,
- Szu-han Huang,
- Howell Moffett,
- Brian D Weitzner,
- Luke Cassereau,
- Laura E Baker,
- Bradley Hammerson,
- Christine Saechao,
- Lisa Song,
- Jade Mimms,
- Candace Sims,
- Marc J Lajoie,
- Bijan Boldajipour,
- Scott E Boyken
Affiliations
- Summer Zhuang
- 2Lyell Immunopharma, South San Francisco, CA, USA
- David Chian
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Hajime Hiraragi
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Thaddeus M Davenport
- 1Outpace Bio, Seattle, WA, USA
- Szu-han Huang
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Howell Moffett
- 1Outpace Bio, Seattle, WA, USA
- Brian D Weitzner
- 1Outpace Bio, Seattle, WA, USA
- Luke Cassereau
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Laura E Baker
- 1Outpace Bio, Seattle, WA, USA
- Bradley Hammerson
- 1Outpace Bio, Seattle, WA, USA
- Christine Saechao
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Lisa Song
- 1Outpace Bio, Seattle, WA, USA
- Jade Mimms
- 1Outpace Bio, Seattle, WA, USA
- Candace Sims
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Marc J Lajoie
- 1Outpace Bio, Seattle, WA, USA
- Bijan Boldajipour
- 2Lyell Immunopharma, South San Francisco, CA, USA
- Scott E Boyken
- 1Outpace Bio, Seattle, WA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.1047
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
